我院2009～2011年降糖药用药分析

目的：分析我院降糖药应用的现状和发展趋势。方法对该院2009～2010年降糖药主要品种、销售金额、用药频度（DDDs）和日均费用（DDC）进行统计和分析。结果3年来降糖药销售金额逐年增长，增长率分别为10．30％和36．88％。其中口服降糖药销售金额排序中，阿卡波糖（拜唐苹）连续3年排在第1位，注射用胰岛素类药物中，诺和灵30R笔芯（300 u）销售金额连续3年均位居榜首。结论该院降糖药销售金额和使用数量增长较快，但应用基本稳定，较为合理。

Analysis of the utilization of hypoglycemic drugs in our hospital from 2009 to 2011

Objective To analyze the status and development of utilization of hypoglycemic drugs in our hospital .Methods The use of hypoglycemic drugs from 2009 to 2011 was statistically analyzed ,including the amount of drugs ,consumption sum ,DDDs and DDC .Results The consumption sum of hypoglycemic drugs increased year by year with annual increase rates of 10.30% and 36.88% ,respectively .Acorbose Tablets took the first place in the consective three years .Novolin 30R penfill of all the insulin in-jections took the lead in the consumption quantity and consumption sum over the 3 years .Conclusion The use of hypoglycemic drugs is basically stable and reasonable in spite of their rapid increase in both consumption sum and quantity .